Buscador de publicaciones

 
 
 
 
 

Mostrando 76 a 90 de 1563 publicaciones.

  • Agüero F, Marrugat J, Elosua R, Sala J, Masiá R, Ramos R, Grau M. New myocardial infarction definition affects incidence, mortality, hospitalization rates and prognosis. Eur J Prev Cardiol 2015 Oct; 22(10): 1272-80

    IF: 2.675, Cuartil: 2

    Ver abstract

  • Kastelein JJ, Ginsberg HN, Langslet G, Hovingh GK, Ceska R, Dufour R, Blom D, Civeira F, Krempf M, Lorenzato C, Zhao J, Pordy R, Baccara-Dinet MT, Gipe DA, Geiger MJ, Farnier M. ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia. Eur. Heart J. 2015 Nov; 36(43): 2996-3003

    IF: 15.203, Cuartil: 1, Decil: 1

    Ver abstract

  • Raal FJ, Stein EA, Dufour R, Turner T, Civeira F, Burgess L, Langslet G, Scott R, Olsson AG, Sullivan D, Hovingh GK, Cariou B, Gouni-Berthold I, Somaratne R, Bridges I, Wasserman SM, Gaudet D. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. Lancet 2015 Jan; 385(9965): 331-40

    IF: 39.207, Cuartil: 1, Decil: 1

    Ver abstract

  • Núñez-Gil IJ, Bernardo E, Feltes G, Escaned J, Mejía-Rentería HD, de Agustín JA, Vivas D, Nombela-Franco L, Jiménez-Quevedo P, Macaya C, Fernández-Ortiz A. Platelet function in Takotsubo cardiomyopathy. J. Thromb. Thrombolysis 2015 May; 39(4): 452-8

    IF: 2.039, Cuartil: 3

    Ver abstract

  • Regueiro A, Freixa X, Fernández-Rodríguez D, Diaz-Ricart M, Escolar G, Martín-Yuste V, Brugaletta S, Sabaté M, Masotti M. Platelet reactivity assessment with VerifyNow®: substitute or complement for light transmission aggregometry? Int. J. Cardiol. 2015 Jan; 178: 221-2

    IF: 15.179, Cuartil: 1, Decil: 1

    Ver abstract

  • Agüero F, González-Zobl G, Baena-Diez JM, Dégano IR, Garcia-Gil M, Alzamora MT, Marrugat J, Comas-Cufí M, Pera G, Elosua R, Ramos R, Grau M. Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders. Atherosclerosis 2015 Sep; 242(1): 1-7

    IF: 3.994, Cuartil: 1

    Ver abstract

  • Fernández-Friera L, Peñalvo JL, Fernández-Ortiz A, Ibáñez B, López-Melgar B, Laclaustra M, Oliva B, Mocoroa A, Mendiguren J, Martínez de Vega V, García L, Molina J, Sánchez-González J, Guzmán G, Alonso-Farto JC, Guallar E, Civeira F, Sillesen H, Pocock S, Ordovas JM, Sanz G, Jiménez-Borreguero LJ, Fuster V. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation 2015 Jun; 131(24): 2104-13

    IF: 15.703, Cuartil: 1, Decil: 1

    Ver abstract

  • Villanueva MP, Mollar A, Palau P, Carratalá A, Núñez E, Santas E, Bodí V, Chorro FJ, Miñana G, Blasco ML, Sanchis J, Núñez J. Procalcitonin and long-term prognosis after an admission for acute heart failure. Eur. J. Intern. Med. 2015 Jan; 26(1): 42-8

    IF: 2.3, Cuartil: 1

    Ver abstract

  • Núñez J, Merlos P, Fácila L, Llàcer P, Bosch MJ, Bertomeu-Martínez V, García-Blas S, Montagud V, Pedrosa V, Mendizábal A, Cordero A, Miñana G, Sanchis J, Bertomeu-González V. Prognostic Effect of Carbohydrate Antigen 125-guided Therapy in Patients Recently Discharged for Acute Heart Failure (CHANCE-HF). Study Design. Rev Esp Cardiol 2015 Aug;

    IF: 3.342, Cuartil: 2

    Ver abstract

  • Santas E, Sandino J, Chorro FJ, Méndez J, Miñana G, Núñez E, Sanchis J, Núñez J. Prognostic implications of pericardial effusion in acute heart failure: Does size matter? Int. J. Cardiol. 2015 Apr; 184: 259-61

    IF: 6.175, Cuartil: 1, Decil: 1

    Ver abstract

  • Santas E, García-Blas S, Miñana G, Sanchis J, Bodí V, Escribano D, Muñoz J, Chorro FJ, Núñez J. Prognostic implications of tissue Doppler imaging-derived e/ea ratio in acute heart failure patients. Echocardiography 2015 Feb; 32(2): 213-20

    IF: 1.254, Cuartil: 3

    Ver abstract

  • Núñez J, Rabinovich GA, Sandino J, Mainar L, Palau P, Santas E, Villanueva MP, Núñez E, Bodí V, Chorro FJ, Miñana G, Sanchis J. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure. PLoS ONE 2015; 10(4): e0122360

    IF: 3.534, Cuartil: 1, Decil: 1

    Ver abstract

  • Navalpotro-Gomez I, Rodríguez-Campello A, Vivanco-Hidalgo RM, Vivas E, Roquer-González J. Progressive gait disorder and epilepsy secondary to venous stroke due to dural arteriovenous fistula type iii. Neurologia 2015 Sep; 30(7): 450-1

    IF: 1.352, Cuartil: 3

    Ver abstract

  • Anguita Sánchez M, Bertomeu Martínez V, Cequier Fillat A. Quality of Vitamin K Antagonist Anticoagulation in Spain: Prevalence of Poor Control and Associated Factors. Rev Esp Cardiol (Engl Ed) 2015 Sep; 68(9): 761-8

    IF: 3.792, Cuartil: 2

    Ver abstract

  • Alfonso F, Perez-Vizcayno MJ, Cárdenas A, García Del Blanco B, García-Touchard A, López-Minguez JR, Rivero F, Masotti M, Zueco J, Cequier A, Morís C, Fernández-Ortiz A, Escaned J, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C. Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis). EuroIntervention 2015 Jul; 11(3): 336-42

    IF: 3.758, Cuartil: 2

    Ver abstract

Una iniciativa de

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar